The DOI matches its Crossref record; 80 of the 80 references it cites were found in a registry or an index.
The association between anxiety and C-reactive protein (CRP) levels: Results from the Northern Finland 1966 Birth Cohort Study
Abstract
BACKGROUND: Anxiety frequently accompanies low-grade inflammation-associated conditions like depression, insulin resistance, coronary heart disease and metabolic syndrome. The association between anxiety and low-grade inflammation is, unlike between depression and low-grade inflammation, a very sparsely studied area in general populations. The aim of the present study was to investigate whether anxiety symptoms as well as comorbid anxiety and depressive symptoms are associated with low-grade inflammation at population level. METHODS: The general population-based Northern Finland 1966 Birth Cohort was followed until age 31 (n=2688 males and 2837 females), when the highly sensitive CRP concentrations were measured. Anxiety and depressive symptoms were defined by Hopkins Symptom Checklist-25 (HSCL-25). RESULTS: After adjusting for confounders, logistic regression analyses showed that anxiety symptoms alone increased the probability for elevated hs-CRP levels (>3.0mg/L) in males over two-fold (2.19 CI 95% 1.08-4.46), while comorbid anxiety and depressive symptoms caused a 1.7-fold (1.76 CI 95% 1.13-2.74) increase in the probability for elevated hs-CRP levels (1.0-3.0mg/L). CONCLUSIONS: Our results support the hypothesis that anxiety as well as comorbid anxiety and depression can be associated with an increased risk for low-grade inflammation in males at population level.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Obese individuals exhibiting elevated inflammation, particularly increases in CRP, are more likely to meet criteria for metabolic syndrome and to develop MDD and anxiety [65].”
From The menace of obesity to depression and anxiety prevalence (2022) · cites this paper as [65]
Citations
Cites
Pearson, T. A., Mensah, G. A., Alexander, R. W., Anderson, J. L., Cannon, R. O., Criqui, M., Fadl, Y. Y., Fortmann, S. P., Hong, Y., Myers, G. L., et al. (2003) · Circulation · doi:10.1161/01.cir.0000052939.59093.45 · Cited by 6,401
C-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes Mellitus
Pradhan, A. D. (2001) · JAMA · doi:10.1001/jama.286.3.327 · Cited by 4,433
SCL-90: an outpatient psychiatric rating scale--preliminary report.
Derogatis, L. R., Lipman, R. S., & Covi, L. (1973) · PubMed · Cited by 3,800
Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis.
Howren, M. B., Lamkin, D. M., & Suls, J. (2009) · Psychosomatic Medicine · doi:10.1097/psy.0b013e3181907c1b · Cited by 2,766
Chronic Subclinical Inflammation as Part of the Insulin Resistance Syndrome
Festa, A., D’Agostino, R., Howard, G., Mykkänen, L., Tracy, R. P., & Haffner, S. M. (2000) · Circulation · doi:10.1161/01.cir.102.1.42 · Cited by 2,366
The HPA axis in major depression: classical theories and new developments
Pariante, C. M., & Lightman, S. L. (2008) · Trends in Neurosciences · doi:10.1016/j.tins.2008.06.006 · Cited by 2,009
Köenig, W., Sund, M., Fröhlich, M., Fischer, H.-G., Löwel, H., Döring, A., Hutchinson, W. L., & Pepys, M. B. (1999) · Circulation · doi:10.1161/01.cir.99.2.237 · Cited by 1,952
Physical Activity and Mental Health: Current Concepts
Paluska, S. A., & Schwenk, T. L. (2000) · Sports Medicine · doi:10.2165/00007256-200029030-00003 · Cited by 1,722
Cytokine-Associated Emotional and Cognitive Disturbances in Humans
Reichenberg, A., Yirmiya, R., Schuld, A., Kraus, T., Haack, M., Morag, A., & Pollmächer, T. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.5.445 · Cited by 1,365
Katon, W. J. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00273-7 · Cited by 1,248
Cited by
Sorted by citations
Elevated C-Reactive Protein Levels, Psychological Distress, and Depression in 73 131 Individuals
Wium-Andersen, M. K., Ørsted, D. D., Nielsen, S. F., & Nordestgaard, B. G. (2013) · JAMA Psychiatry · doi:10.1001/2013.jamapsychiatry.102 · Cited by 489
Anxiety disorders and inflammation in a large adult cohort
Vogelzangs, N., Beekman, A. T. F., de Jonge, P., & Penninx, B. W. J. H. (2013) · Translational Psychiatry · doi:10.1038/tp.2013.27 · Cited by 458
“Two recent studies have correlated anxiety symptoms with increased cytokine levels, in particular C-reactive protein (CRP).(14,15) With regard to anxiety disorders, research has mainly focused on posttraumatic stress disorder, in which high levels of inflammatory markers have been found.”
BackgroundBlake, M. J., Trinder, J. A., & Allen, N. B. (2018) · Clinical Psychology Review · doi:10.1016/j.cpr.2018.05.006 · Cited by 477
The menace of obesity to depression and anxiety prevalence
Fulton, S., Décarie-Spain, L., Fioramonti, X., Guiard, B., & Nakajima, S. (2022) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2021.10.005 · Cited by 441
“Obese individuals exhibiting elevated inflammation, particularly increases in CRP, are more likely to meet criteria for metabolic syndrome and to develop MDD and anxiety [65].”
BackgroundTreatment-resistant depression and peripheral C-reactive protein.
Chamberlain, S. R., Cavanagh, J., de Boer, P., Mondelli, V., Jones, D. N. C., Drevets, W. C., Cowen, P. J., Harrison, N. A., Pointon, L., Pariante, C. M., et al. (2019) · British Journal of Psychiatry · doi:10.1192/bjp.2018.66 · Cited by 400
Slavich, G. M., & Sacher, J. (2019) · Psychopharmacology · doi:10.1007/s00213-019-05326-9 · Cited by 383
“…also be considered in light of studies showing male-specific associations between inflammatory markers (Ramsey et al., 2016)—in particular, CRP— and symptoms of anxiety and depression (Elovainio et al. 2009; Liukkonen et al. 2011; Vetter et al. 2013; Vogelzangs et al. 2012; see Raison et al. 2005).”
Power, M. C., Kioumourtzoglou, M., Hart, J. E., Okereke, O. I., Laden, F., & Weisskopf, M. G. (2015) · BMJ · doi:10.1136/bmj.h1111 · Cited by 380
Lopresti, A. L., Maker, G. L., Hood, S. D., & Drummond, P. D. (2014) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.09.017 · Cited by 371
“…men with an older age of depression onset (Vogelzangs et al., 2012), depressed men in general (Elovainio et al., 2009, Ford and Erlinger, 2004, Liukkonen et al., 2011), depressed patients with a greater history of childhood adversity (Miller and Cole, 2012), and cumulative depressive episodes…”
BackgroundSex differences in the neuro-immune consequences of stress: Focus on depression and anxiety
Bekhbat, M., & Neigh, G. N. (2017) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2017.02.006 · Cited by 376
“In fact, C-reactive protein (CRP), one of the most consistently reported inflammatory biomarkers of mood disorders, was recently found to be associated with anxiety and comorbid anxiety and depression in men, but not women (Liukkonen et al 2011).”
BackgroundDopamine, Immunity, and Disease
Channer, B., Matt, S. M., Nickoloff-Bybel, E. A., Pappa, V., Agarwal, Y., Wickman, J. R., & Gaskill, P. J. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.122.000618 · Cited by 328
Comorbid Anxiety and Depression: Clinical and Conceptual Consideration and Transdiagnostic Treatment
Choi, K. W., Kim, Y., & Jeon, H. J. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-981-32-9705-0_14 · Cited by 339
Duivis, H. E., Vogelzangs, N., Kupper, N., de Jonge, P., & Penninx, B. W. J. H. (2013) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2013.01.002 · Cited by 282
“In line with our findings on total symptoms of anxiety, previous studies also reported on a positive association between anxiety and inflammation (Pitsavos et al., 2006; Liukkonen et al., 2011).”
Inflammation-Related Functional and Structural Dysconnectivity as a Pathway to Psychopathology
Goldsmith, D. R., Bekhbat, M., Mehta, N. D., & Felger, J. C. (2022) · Biological Psychiatry · doi:10.1016/j.biopsych.2022.11.003 · Cited by 229
“between CRP/cytokines and anxiety (62-64), including longitudinally (65) and depression (66).”
Peripheral Markers of Depression
Nobis, A., Zalewski, D., & Waszkiewicz, N. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9123793 · Cited by 197
Low-grade inflammation predicts persistence of depressive symptoms
Zalli, A., Jovanova, O., Hoogendijk, W. J. G., Tiemeier, H. W., & Carvalho, L. A. (2015) · Psychopharmacology · doi:10.1007/s00213-015-3919-9 · Cited by 193
“2014); have comorbid depression with other mental and physical illnesses (Jones et al. 2004; Liukkonen et al. 2011; Moussavi et al. 2007); present earlier onset of the disorder (Grosse et al.”
BackgroundInfluentialCytokine production capacity in depression and anxiety
Vogelzangs, N., de Jonge, P., Smit, J. H., Bahn, S., & Penninx, B. W. J. H. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.92 · Cited by 198
Hou, R., Garner, M., Holmes, C., Osmond, C., Teeling, J., Lau, L., & Baldwin, D. S. (2017) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2017.01.021 · Cited by 191
Baune, B., Smith, E., Reppermund, S., Air, T., Samaras, K., Lux, O., Brodaty, H., Sachdev, P. S., & Trollor, J. N. (2012) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2012.02.006 · Cited by 189
Koller, D., Pathak, G. A., Wendt, F. R., Tylee, D. S., Levey, D. F., Overstreet, C. M., Gelernter, J. E., Taylor, H. S., & Polimanti, R. A. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.51214 · Cited by 155
Tayefi, M., Shafiee, M., Kazemi‐Bajestani, S. M. R., Esmaily, H., Darroudi, S., Khakpouri, S., Mohammadi, M., Ghaneifar, Z., Azarpajouh, M. R., Moohebati, M., et al. (2017) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2017.02.035 · Cited by 125
Tang, F., Wang, G., & Lian, Y. (2017) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2016.11.025 · Cited by 117
Lasselin, J., Elsenbruch, S., Lekander, M., Axelsson, J., Karshikoff, B., Grigoleit, J., Engler, H., Schedlowski, M., & Benson, S. (2016) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2016.01.003 · Cited by 106
Innate Immunity: A Common Denominator between Neurodegenerative and Neuropsychiatric Diseases
Novellino, F., Saccà, V., Donato, A., Zaffino, P., Spadea, M. F., Vismara, M. F. M., Arcidiacono, B., Malara, N., Presta, I., & Donato, G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21031115 · Cited by 107
“Abbreviations AD Alzheimer’s disease ALS Amyotrophic lateral sclerosis BBB Blood-brain barrier CNS Central nervous system CRP C-reactive protein CD Crohn’s disease CXCL “C-X-C” motif chemokine ligand CXCR “C-X-C” motif chemokine receptor DAMP Damage associated molecular pattern DC Dendritic cell DPR Dipeptide repeats…”
BackgroundInfluentialHickman, R. J., Khambaty, T., & Stewart, J. C. (2014) · Journal of Behavioral Medicine · doi:10.1007/s10865-013-9510-0 · Cited by 90
“This is surprising, given that positive associations between anxiety measures and inflammatory markers have been reported (Bankier et al., 2009; Herrán et al., 2005; Liukkonen et al., 2011) and that anxiety is also thought to be a risk factor for CAD (Suls & Bunde, 2005).”
BackgroundTriggers for Atrial Fibrillation: The Role of Anxiety
Severino, P., Mariani, M. V., Maraone, A., Piro, A., Ceccacci, A., Tarsitani, L., Maestrini, V., Mancone, M., Lavalle, C., Pasquini, M., et al. (2019) · Cardiology Research and Practice · doi:10.1155/2019/1208505 · Cited by 86
Neighborhood stressors and cardiovascular health: Crime and C-reactive protein in Dallas, USA
Browning, C. R., Cagney, K. A., & Iveniuk, J. (2012) · Social Science & Medicine · doi:10.1016/j.socscimed.2012.03.027 · Cited by 82
“…Woods, & Page, 2009; McCanlies et al., 2011; Rohleder & Karl, 2006; Spitzer et al., 2010), anxiety (Bankier, Barajas, MartinezRumayor, & Januzzi, 2009; Liukkonen et al., 2011), mental stress (Owen et al., 2003), and depression (Ford & Erlinger, 2004; Suarez, 2004) exhibit elevated CRP levels.”
The Association Between Obesity and Low Back Pain and Disability Is Affected by Mood Disorders
Chou, L., Brady, S. R. E., Urquhart, D. M., Teichtahl, A. J., Cicuttini, F., Pasco, J. A., Brennan-Olsen, S. L., & Wluka, A. E. (2016) · Medicine · doi:10.1097/md.0000000000003367 · Cited by 85
Modulating Neuroinflammation to Treat Neuropsychiatric Disorders
Radtke, F., Chapman, G., Hall, J., & Syed, Y. A. (2017) · BioMed Research International · doi:10.1155/2017/5071786 · Cited by 80
“Elevated levels of pro-inflammatory cytokines like IL-6 and IL-1β can lead to the production of this acute phase protein in the liver [14, 23-28].”
BackgroundUlmer-Yaniv, A., Djalovski, A., Yirmiya, K., Halevi, G., Zagoory‐Sharon, O., & Feldman, R. (2017) · Psychological Medicine · doi:10.1017/s0033291717002550 · Cited by 72
“2012), as well as in anxious individuals (O’Donovan et al. 2010; Liukkonen et al. 2011; Vogelzangs et al. 2013).”
BackgroundThe Role of Anxious Distress in Immune Dysregulation in Patients with Major Depressive Disorder
Gaspersz, R., Lamers, F., Wittenberg, G., Beekman, A. T. F., van Hemert, A. M., Schoevers, R. A., & Penninx, B. W. J. H. (2017) · Translational Psychiatry · doi:10.1038/s41398-017-0016-3 · Cited by 71
Glaus, J., von Känel, R., Lasserre, A. M., Strippoli, M.-P. F., Vandeleur, C. L., Castelao, E., Gholam-Rezaee, M., Marangoni, C., Wagner, E.-Y. N., Marques-Vidal, P., et al. (2018) · Depression and Anxiety · doi:10.1002/da.22710 · Cited by 64
“…is limited and comorbidity with other mental disorders has not always been taken into consideration (Gill, Saligan, Woods, & Page, 2009; Khandaker, Zammit, Lewis, & Jones, 2016; Liukkonen et al., 2011; Pitsavos et al., 2006; Turna et al., 2016; Vogelzangs, Beekman, de Jonge, & Penninx, 2013).”
BackgroundMaternal depression and inflammation during pregnancy
Lahti‐Pulkkinen, M., Girchenko, P. V., Robinson, R., Lehto, S. M., Toffol, E., Heinonen, K., Reynolds, R. M., Kajantie, E., Laivuori, H. M., Villa, P., et al. (2019) · Psychological Medicine · doi:10.1017/s0033291719001909 · Cited by 69
Suija, K., Timonen, M., Suviola, M., Jokelainen, J. J., Järvelin, M., & Tammelin, T. (2013) · BMC Public Health · doi:10.1186/1471-2458-13-535 · Cited by 67
“We used data of national Finnish hospital discharge register about the presence of lifetime hospital-treated somatic disease [28].”
MethodNiles, A. N., Smirnova, M., Lin, J. E., & O’Donovan, A. (2018) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2018.05.035 · Cited by 69
“Because prior studies have found gender differences in the link between depression and anxiety symptoms and inflammation with men typically showing a stronger link than women (Elovainio et al., 2009; Ladwig et al., 2003; Liukkonen et al., 2011; Toker et al., 2005; Vogelzangs et al., 2012, 2013), we also examined inter…”
BackgroundResultInfluentialKhandaker, G. M., Zammit, S., Lewis, G., & Jones, P. B. (2016) · Neurobiology of Stress · doi:10.1016/j.ynstr.2016.02.003 · Cited by 65
Anxiety disorders and CRP in a population cohort study with 54,326 participants: The LifeLines study
Naudé, P. J. W., Roest, A. M., Stein, D. J., de Jonge, P., & Doornbos, B. (2018) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2018.1433325 · Cited by 67
“Six large studies have investigated the relation between anxiety disorders and CRP (Pitsavos et al. 2006; Liukkonen et al. 2011; Copeland et al. 2012; Vogelzangs et al. 2013; Wagner et al. 2015; Tayefi et al. 2017); all found that anxiety disorders are significantly associated with increased CRP…”
BackgroundResultInfluentialVagotomy and insights into the microbiota-gut-brain axis
Liu, Y., & Forsythe, P. (2021) · Neuroscience Research · doi:10.1016/j.neures.2021.04.001 · Cited by 67
Lopez, R. B., Denny, B. T., & Fagundes, C. P. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.10.019 · Cited by 64
“Other observational studies, with larger sample sizes (all Ns ≥ 400) and in independent cohorts, have provided converging evidence for the anxiety–inflammation link (Liukkonen et al., 2011; Pitsavos et al., 2006; Vogelzangs et al., 2013).”
Suicidality in subjects with anxiety or obsessive-compulsive and related disorders: recent advances
De La Vega, D., Giner, L., & Courtet, P. (2018) · Current Psychiatry Reports · doi:10.1007/s11920-018-0885-z · Cited by 60
Memon, A. A., Sundquist, K., Ahmad, A., Wang, X., Hedelius, A., & Sundquist, J. (2017) · Psychiatry Research · doi:10.1016/j.psychres.2017.05.012 · Cited by 59
“A single study investigating the role of CRP in anxiety shows that CRP levels were associated with anxiety in males but not in females, further suggesting that role of CRP in anxiety also is gender specific (Liukkonen et al., 2011).”
BackgroundTherapeutic psychological and biological responses to mindfulness‐based art therapy
Beerse, M. E., Lith, T. V., & Stanwood, G. D. (2020) · Stress and Health · doi:10.1002/smi.2937 · Cited by 59
Zartaloudi, A., Christopoulos, D., Kelesi, Μ., Govina, O., Μαντζώρου, Μ., Αδαμακίδου, Θ., Karvouni, L., Koutelekos, I. G., Evangelou, E., Fasoi, G., et al. (2023) · Diseases · doi:10.3390/diseases11020066 · Cited by 74
C‐reactive protein, early life stress, and wellbeing in healthy adults
Carpenter, L. L., Gawuga, C. E., Tyrka, A. R., & Price, L. H. (2012) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2012.01892.x · Cited by 49
“Previously published findings include elevated concentrations of CRP in patients with depression, as well as independent or mediating effects of distress, depression, and anxiety symptoms from statistical models predicting CRP (25, 30, 76, 77), so additional interpretation of our notable negative finding in this domai…”
BackgroundLiu, Y., Mian, M. F., Neufeld, K. M., & Forsythe, P. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.04.014 · Cited by 49
Beerse, M. E., Van Lith, T., Pickett, S. M., & Stanwood, G. D. (2020) · Experimental Biology and Medicine · doi:10.1177/1535370219883634 · Cited by 45
Swartz, J. R., Prather, A. A., & Hariri, A. R. (2017) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2017.01.024 · Cited by 42
“…however, sex differences in the association between inflammation and internalizing problems have not always been consistent, with other studies finding a positive association between CRP levels and anxiety symptoms or disorders in men but not women (Liukkonen et al., 2011; Vogelzangs et al., 2013).”
ResultDepression and worry symptoms predict future executive functioning impairment via inflammation
Zainal, N. H., & Newman, M. G. (2021) · Psychological Medicine · doi:10.1017/s0033291721000398 · Cited by 38
“Findings concur with the fact that elevated depression, GAD, and post-traumatic stress disorder were related to subsequent increased inflammation 3–31 years later among young, mid-life, and older community adults in the United States (Copeland et al., 2012a, 2012b; Niles et al., 2018), Finland (Liukkonen et al., 2006,…”
BackgroundAnxiety independently contributes to elevated inflammation in humans with obesity
Pierce, G. L., Kalil, G. Z., Ajibewa, T., Holwerda, S. W., Persons, J., Moser, D. J., & Fiedorowicz, J. G. (2017) · Obesity · doi:10.1002/oby.21698 · Cited by 33
“Inconsistent findings may be from inclusion of participants with predominantly lower BMI (3,6,7).”
BackgroundInfluentialKim, J.-R., Kim, H.-N., & Song, S.-W. (2018) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-018-0367-9 · Cited by 33
Hole, C., Dhamsania, A., Brown, C., & Ryznar, R. J. (2025) · Cells · doi:10.3390/cells14080607 · Cited by 37
“Some studies have also linked high CRP levels with anxiety, particularly in men, suggesting that hormonal differences may influence both inflammation and anxiety [32].”
Morales‐Muñoz, I., Palmer, E. R., Marwaha, S., Mallikarjun, P. K., & Upthegrove, R. (2021) · Biological Psychiatry · doi:10.1016/j.biopsych.2021.12.003 · Cited by 31
Mehta, N. D., Stevens, J. S., Li, Z., Fani, N., Gillespie, C. F., Ravi, M., Michopoulos, V., & Felger, J. C. (2022) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2022.06.013 · Cited by 33
Santoft, F., Hedman‐Lagerlöf, E., Salomonsson, S., Lindsäter, E., Ljótsson, B., Kecklund, G., Lekander, M., & Andréasson, A. (2020) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2020.100045 · Cited by 31
Basal and LPS-stimulated inflammatory markers and the course of anxiety symptoms
van Eeden, W. A., Filali, E. E., van Hemert, A. M., Carlier, I. V. E., Penninx, B. W. J. H., Lamers, F., Schoevers, R. A., & Giltay, E. J. (2021) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2021.09.001 · Cited by 30
“, 2015) and anxiety symptoms in general (Liukkonen et al., 2011; Pitsavos et al., 2006).”
BackgroundKoks, N., Ghassabian, A., Greaves‐Lord, K., Albert Hofman, D., Jaddoe, V. W. V., Verhulst, F. C., & Tiemeier, H. W. (2015) · Paediatric and Perinatal Epidemiology · doi:10.1111/ppe.12261 · Cited by 29
Role of PPARs in Progression of Anxiety: Literature Analysis and Signaling Pathways Reconstruction
Рудько, О. И., Tretiakov, A. V., Наумова, Е. А., & Климов, Е. А. (2020) · PPAR Research · doi:10.1155/2020/8859017 · Cited by 24
Yu, H., Yu, B., Qin, X., & Shan, W. (2023) · Journal of Affective Disorders · doi:10.1016/j.jad.2023.07.005 · Cited by 25
High‐sensitivity CRP: Possible link between job stress and atherosclerosis
Xu, W., Chen, B., Guo, L., Li, Z., Zhao, Y., & Zeng, H. (2015) · American Journal of Industrial Medicine · doi:10.1002/ajim.22470 · Cited by 25
“According to the previous studies [Liukkonen et al., 2011; Niu et al., 2012], 3.0mg/L was used as the cutoff to divide the subjects into two groups: high hs-CRP group (hs-CRP 3.0mg/L) and normal hs-CRP group (hs-CRP <3.0mg/L).”
MethodResultThe Person’s Care Requires a Sex and Gender Approach
Campesi, I., Montella, A., Seghieri, G., & Franconi, F. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10204770 · Cited by 25
Immunocognitive Model of Depression Secondary to Anxiety in Adolescents
Moriarity, D. P., McArthur, B. A., Ellman, L. M., Coe, C. L., Abramson, L. Y., & Alloy, L. B. (2018) · Journal of Youth and Adolescence · doi:10.1007/s10964-018-0905-7 · Cited by 24
Shetty, T., Cogsil, T., Dalal, A., Kim, E., Halvorsen, K., Cummings, K., & Nguyen, J. (2018) · Journal of Head Trauma Rehabilitation · doi:10.1097/htr.0000000000000450 · Cited by 23
Obesity and Depression: A Pathophysiotoxic Relationship
Monsalve, F. A., Fernández-Tapia, B., Arriagada, O., González, D. R., & Delgado‐López, F. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262311590 · Cited by 22
“Obese individuals who exhibit elevated levels of CRP are more likely to develop depression and anxiety [124].”
Cardoso, T. D. A., da Silva, R. H., Fernandes, J. L., Arent, C. O., Amboni, G., Borba, L. A., Padilha, A. P. Z., Botelho, M. E. M., Maciel, A. L., Barichello, T., et al. (2023) · Journal of Affective Disorders · doi:10.1016/j.jad.2023.03.019 · Cited by 23
“In both COVID-19 infection and mood disorder, such as depression and anxiety, CRP concentrations are elevated (Iglesias-Gonz ´ alez et al., 2022; Liukkonen et al., 2011; Morales-Mu ˜ noz et al., 2022).”
The Relationship Between Race, Inflammation and Psychosocial Factors Among Pregnant Women
Catov, J. M., Flint, M. S., Lee, M., Roberts, J. M., & Abatemarco, D. J. (2014) · Maternal and Child Health Journal · doi:10.1007/s10995-014-1522-z · Cited by 25
“study of younger adults (mean age 31), increasing anxiety was associated with higher concentrations of CRP in men, but not in women [48].”
Zou, B., Miao, C., & Chen, J. (2020) · Risk Management and Healthcare Policy · doi:10.2147/rmhp.s270359 · Cited by 20
Gündoğmuş, A. G., Katar, K. S., Örsel, S., Öztürk, G., & Yılmaz, K. B. (2022) · PLoS ONE · doi:10.1371/journal.pone.0277119 · Cited by 19
“There was a positive correlation between the hsCRP level and the HAD-depression score among all the patients, which is consistent with the literature [26, 27, 57].”
ResultMalik, S., Alnaji, O., Malik, M., Gambale, T., & Rathbone, M. P. (2022) · Brain Sciences · doi:10.3390/brainsci12010102 · Cited by 22
“Similarly, patients with depression and anxiety have upregulated CRP levels in comparison to controls [67,70,71].”
BackgroundMamun-or-Rashid, Roknuzzaman, A. S. M., Sarker, R., Nayem, J., Bhuiyan, M. A., Islam, M. R., & Mahmud, Z. A. (2024) · Scientific Reports · doi:10.1038/s41598-024-66131-9 · Cited by 17
Kheirabadi, G. R., Toghani, F., Kousha, M., Hashemi, M., Maracy, M. R., Maracy, M. R., & Bagherian-Sararoudi, R. (2013) · Europe PMC (PubMed Central) · Cited by 17
The incidence and risk of osteoporosis in patients with anxiety disorder
Chen, H.-J., Chin-Yuan, K., Tu, M., Wang, F., Chen, R.-Y., Hsueh, K.-C., Pan, H.-J., Ming-Yueh, C., Chen, P., & Pan, C. (2016) · Medicine · doi:10.1097/md.0000000000004912 · Cited by 16
Marti, C. N., Choi, N. G., DiNitto, D. M., & Choi, B. Y. (2015) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2015.02.008 · Cited by 17
Bagherniya, M., Khayyatzadeh, S. S., Avan, A., Safarian, M., Nematy, M., Ferns, G. A., Mokhber, N., & Ghayour‐Mobarhan, M. (2017) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2017.04.005 · Cited by 18
“association between hs-CRP with anxiety (52, 53) and depression (51, 54).”
BackgroundImpaired PARP activity in response to the β-adrenergic receptor agonist isoproterenol
Thomas, M., Palombo, P., Schuhmacher, T., von Scheven, G., Bazylianska, V., Salzwedel, J., Schäfer, N., Bürkle, A., & Moreno‐Villanueva, M. (2018) · Toxicology in Vitro · doi:10.1016/j.tiv.2018.02.001 · Cited by 16
Hu, X., Fu, H., Zhang, L., Zhang, Q., Xu, T., Chen, Y., Chen, G., Jiang, S., Ji, J., Xie, H. Q., et al. (2024) · Environment & Health · doi:10.1021/envhealth.4c00059 · Cited by 15
Reddaway, J., & Brydges, N. M. (2020) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2020.103567 · Cited by 17
Sexually dimorphic organization of open field behavior following moderate prenatal alcohol exposure
Oltmanns, J. R. O., Schaeffer, E. A., Gonçalves-Garcia, M., Donaldson, T. N., Acosta, G. B., Sanchez, L. M., Davies, S., Savage, D. D., Wallace, D. G., & Clark, B. J. (2022) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.14813 · Cited by 13
Childhood adversities and adult-onset asthma: a cohort study
Korkeila, J. J. A., Lietzén, R., Sillanmäki, L. H., Rautava, P. T., Korkeila, K., Mika Kivimaki, B., Koskenvuo, M. J., & Vahtera, J. (2012) · BMJ Open · doi:10.1136/bmjopen-2012-001625 · Cited by 13
“50 Also anxiety disorders have been linked to inflammation.(51) It has been suggested that stress-related elevation in clinically relevant inflammation proteins could contribute to the biological embedding of childhood stress.”
BackgroundFields, A. J., Hoyt, R. E., Linnville, S. E., & Moore, J. L. (2015) · Journal of Health Psychology · doi:10.1177/1359105314568578 · Cited by 14
“Liukkonen et al. (2011) found in males that the probability of CRP in the highest tertile (CRP > 3.0 mg/L) increases over twofold in those with symptoms of anxiety disorder, while Pitsavos et al. (2006) reported male participants in the upper tertile of the Spielberger State Anxiety Inventory…”
BackgroundInfluentialHagen, J. M., Sutterland, A. L., de Sousa, P. A. L. D. F. P., Schirmbeck, F. N., Cohn, D. M., Lok, A., Tan, H. L., Zwinderman, A. H., & de Haan, L. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.06.040 · Cited by 12
Nguyen‐Rodriguez, S. T., Gallo, L. C., Isasi, C. R., Buxton, O. M., Thomas, K. S., Sotres‐Alvarez, D., Redline, S. S., Castañeda, S. F., Carnethon, M. R., Daviglus, M. L., et al. (2020) · Annals of Behavioral Medicine · doi:10.1093/abm/kaz070 · Cited by 10
Bai, B., Yin, H., Wang, H., Liu, F., Liang, Y., Liu, A., Guo, L., Ma, H., & Geng, Q. (2024) · BMC Psychiatry · doi:10.1186/s12888-024-06158-4 · Cited by 10
“A recent meta-analysis showed that depression and anxiety are associated with high levels of inflammatory markers, such as C-reactive protein [14–19].”
BackgroundТРЕВОЖНО-ДЕПРЕССИВНЫЕ РАССТРОЙСТВА У ПАЦИЕНТОВ С МЕТАБОЛИЧЕСКИМ СИНДРОМОМ
Moskalenko, O. L., Smirnova, O. V., Tereshchenko, S. Y., & Каспаров, Э. В. (2021) · Russian Journal of Education and Psychology · doi:10.12731/2658-4034-2021-12-4-118-137 · Cited by 9
Origin of Sex-Biased Mental Disorders: Do Males and Females Experience Different Selective Regimes?
Brown, C. M., Wong, Q. Y., Thakur, A., Singh, K. K., & Singh, R. S. (2022) · Journal of Molecular Evolution · doi:10.1007/s00239-022-10072-2 · Cited by 7
Kridin, K., Hundt, J. E., Ludwig, R. J., Schonmann, Y., & Cohen, A. D. (2021) · Current Psychology · doi:10.1007/s12144-021-01396-1 · Cited by 10
Anxiety, C-reactive protein, and obesity in NHANES 1999–2004
Persons, J. E., Pierce, G. L., & Fiedorowicz, J. G. (2019) · Heliyon · doi:10.1016/j.heliyon.2019.e02267 · Cited by 7
Inflammation and the Brain Disorders: A Review
Bargi, R., Salmani, H., Yazdi, F. A., & Hosseini, M. (2017) · The Neuroscience Journal of Shefaye Khatam · doi:10.18869/acadpub.shefa.5.3.68 · Cited by 7
Guerrero, L. R., Hong, S., Tarraf, W., Perreira, K. M., Camacho, Á., Kohn, J. N., Jimenez, D. E., Talavera, G. A., Gallo, L. C., Allison, M., et al. (2023) · PLoS ONE · doi:10.1371/journal.pone.0289833 · Cited by 8
“Furthermore, common psychotherapeutic and pharmacologic treatments for generalized anxiety and depressive disorders have shown to decrease biomarkers of inflammation [5, 7, 15, 16].”
BackgroundXu, R., Lu, L., Yuan, T., Chen, W., Wei, J., Shi, C., Wang, S., Liang, S., Li, Y., Zhong, Z., et al. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.06.007 · Cited by 6
Effects of Nonpharmacological Therapies on Anxiety and Cortisol: A Meta-Analysis
Sagarwala, R., Malmstrom, T. K., & Nasrallah, H. A. (2018) · Annals of Clinical Psychiatry · doi:10.1177/104012371803000203 · Cited by 6
Tan, M., Luo, Y., Hu, J., Hu, K., Li, X., Yang, J., Chen, J., Zhu, W., & Kuang, Y. (2023) · Clinical Cosmetic and Investigational Dermatology · doi:10.2147/ccid.s401934 · Cited by 6
“Moreover, limited data is available on the relation of CRP or ESR to anxiety in psoriasis.(14) Hence, investigation of the correlation between inflammation and depression and characterization of the burden of depression and anxiety using validated patient-reported measurements are urgently needed for patients with pso…”
BackgroundKumaraguru, M., Chellappa, L. R., Arumugham, M. I., & Jayaraman, S. (2023) · Cureus · doi:10.7759/cureus.46065 · Cited by 5
“Previous research has shown that depressed patients have higher levels of CRP [25,26].”
Cardiolipin Antibody: A Potential Biomarker for Depression
Costa, R., Fatourou, E., Hoppensteadt, D., Fareed, J., & Halaris, A. E. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12111759 · Cited by 5
“reported that C-reactive protein to be associated with depression in men, but not in women [24].”
BackgroundParent, C. I., Pokhvisneva, I., Gaudreau, H., Meaney, M. J., & Silveira, P. P. (2019) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2019.01.007 · Cited by 5
Brambila‐Tapia, A. J. L., Jacquez-Castañeda, A. L., Carrillo-Delgadillo, L. A., Dávila-Flores, J. N., Macías-Espinoza, F., Santos, S. R.-D. L., & Gutiérrez-Hurtado, I. A. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13050876 · Cited by 5
“Considering the inclusion of other non-psychological variables in the multivariate regression analysis of the global sample, including the frequency of alcohol consumption, which was positively associated with hs-CRP in the global and women’s samples, is explained by the possible irritant effect that alcohol produces…”
BackgroundResultInfluentialHowren, A. M., Sayre, E. C., Aviña-Zubieta, J. A., Puyat, J. H., Costa, D. D., Xie, H. W., Davidson, E., & Vera, M. A. D. (2024) · Arthritis Care & Research · doi:10.1002/acr.25294 · Cited by 5
Nayek, S., & Ghosh, S. (2018) · The Journal of Medical Research · doi:10.31254/jmr.2018.4304 · Cited by 5
Key, K. V., Mudd‐Martin, G., Moser, D. K., Rayens, M. K., & Morford, L. A. (2020) · The Journal of Cardiovascular Nursing · doi:10.1097/jcn.0000000000000742 · Cited by 5
“Results from previous studies have indicated that anxiety is associated with increased levels of systemic inflammation, 3,6,34,35 supporting the hypothesis that symptoms of anxiety activate the sympathetic nervous and immune systems, which, in turn, stimulate the secretion of pro-inflammatory…”
Ji, D., Francesconi, M., Flouri, E., & Papachristou, E. (2022) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2022.07.002 · Cited by 6
Lymphatics: Future Perspectives Unrealized Potential
Houck, P. D., Dandapantula, H. K., & Massey, J. M. (2023) · Lymphatics · doi:10.3390/lymphatics1020009 · Cited by 5
Effects of elevated emotional symptoms on metabolic disease development: a 10-year follow-up study
Sánchez‐Carro, Y., de la Torre‐Luque, A., Vassou, C., López-García, P., Georgousopoulou, E. N., Pitsavos, C. E., Ayuso‐Mateos, J. L., & Panagiotakos, D. B. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1148643 · Cited by 4
Metadata
- Authors
- Liukkonen, T., Räsänen, P., Jokelainen, J., Leinonen, M., Järvelin, M.-R., Meyer-Rochow, V. B., & Timonen, M.
- Affiliations
- Savonlinna Central Hospital (FI)
- University of Oulu (FI)
- Oulu University Hospital (FI)
- Finnish Institute for Health and Welfare (FI)
- Imperial College London (GB)
- Corresponding author
- Liukkonen, T.
- Venue
- European Psychiatry
- Publisher
- Cambridge University Press (CUP)
- Published
- 2011-09
- Volume
- 26
- Issue
- 6
- Pages
- 363-369
- ISSN
- 0924-9338 (ISSN-L)
- 1778-3585
- OpenAlex
- W2057674272
- Cited by
- 127
- References
- 80
- Citations by year
- 2026: 1 · 2025: 5 · 2024: 6 · 2023: 13 · 2022: 12 · 2021: 10 · 2020: 14 · 2019: 7 · 2018: 12 · 2017: 14 · 2016: 7 · 2015: 7 · 2014: 5 · 2013: 8 · 2012: 5
- FWCI
- 1.67
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- STM:n Hallinnonalan avoin julkaisuarkisto (Julkari) (submittedVersion)
- Funders
- Suomen Kulttuurirahasto
- Topics
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- anxiety, C-reactive protein, low-grade inflammation, depressive symptoms, comorbid depression and anxiety, Hopkins Symptom Checklist-25, Northern Finland Birth Cohort 1966, sex differences, young adults
- MeSH terms
- Adult, Anxiety, Anxiety Disorders, C-Reactive Protein, Depression, Depressive Disorder, Female, Finland, Humans, Male, Surveys and Questionnaires, Comorbidity, Prevalence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review